The University of Chicago Header Logo

Connection

James J. Dignam to Bevacizumab

Back to Details
This is a "connection" page, showing publications James J. Dignam has written about Bevacizumab.
James J. Dignam
Connection Strength
0.053
Bevacizumab
  1. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014 Feb 20; 370(8):699-708.
    View in: PubMed
    Score: 0.028
  2. Integrated phase II/III clinical trials in oncology: a case study. Clin Trials. 2012 Dec; 9(6):741-7.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.